Cooper C. Collins - 18 Nov 2021 Form 4 Insider Report for TherapeuticsMD, Inc. (TXMD)

Role: Director
Signature: /s/ Cooper C. Collins
Issuer symbol: TXMD
Transactions as of: 18 Nov 2021
Net transactions value: +$578,500
Form type: 4
Filing time: 22 Nov 2021, 05:30:08 UTC
Previous filing: 19 Aug 2021
Next filing: 22 Aug 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TXMD	Common Stock	Purchase	$578,500	+1,000,000	+81%	$0.5785	2,236,864	18 Nov 2021	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. The reported securities were purchased in multiple transactions with prices ranging from $0.5581 to $0.5850 for an average weighted purchase price of $0.5785. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Content

The price reported in Column 4 is a weighted average price. The reported securities were purchased in multiple transactions with prices ranging from $0.5581 to $0.5850 for an average weighted purchase price of $0.5785. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.